Diclofenac associated with cardiovascular health risk

A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...

Vaccinations: pointing the needle in expanded settings

Pharmacists should be able to administer vaccinations in any health setting. Appropriately trained and qualified pharmacists across all Australian states and territories can administer...

Q&A: ‘I’m going overseas tomorrow . . . can you witness...

While pharmacists are now (very) familiar with rapid antigen tests (RATs) for COVID-19 testing, the practice of observed RATs for the purpose of international...

Call for pharmacist access to the MBS for Chronic Disease Management

Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense. After a...

Treating hypertension – a new approach

Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological...

Ready-to-use tool for oncology

Pharmacists have a new oncology-focused tool for the evaluation and assessment of adverse drug events in oncology. French researchers have developed a trigger tool to...